On May 7, 2020, the Wellcome Sanger Institute announced that Roser Vento-Tormo, a Group Leader was one of the recipients of funding from the Chan Zuckerberg Initiative (CZI) to study how COVID-19 progresses in patients, at the level of individual cells and tissues. CZI suppored five projects studying COVID-19 progression, with a total of $750,000 funding.